Total Payments
$2,301
2024 Payments
$1,248
Companies
17
Transactions
125
Medicare Patients
1,944
Medicare Billing
$146,620
Payment Breakdown by Category
Food & Beverage$2,201 (95.7%)
Education$99.99 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,201 | 124 | 95.7% |
| Education | $99.99 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $501.21 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $403.88 | 12 | $0 (2024) |
| ABBVIE INC. | $349.63 | 25 | $0 (2024) |
| Amgen Inc. | $214.25 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $173.41 | 9 | $0 (2024) |
| Incyte Corporation | $146.67 | 4 | $0 (2024) |
| GENZYME CORPORATION | $134.26 | 3 | $0 (2024) |
| PFIZER INC. | $125.74 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $69.39 | 4 | $0 (2024) |
| UCB, Inc. | $69.34 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,248 | 70 | Janssen Biotech, Inc. ($287.33) |
| 2023 | $779.99 | 37 | Amgen Inc. ($163.57) |
| 2022 | $273.02 | 18 | Novartis Pharmaceuticals Corporation ($144.71) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Immunology | ||||||
| 11/13/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.04 | General |
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $9.29 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,028 | 2,079 | $219,032 | $61,485 |
| 2022 | 15 | 889 | 1,877 | $249,817 | $82,409 |
| 2020 | 2 | 27 | 27 | $9,004 | $2,726 |
Total Patients
1,944
Total Services
3,983
Medicare Billing
$146,620
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 174 | $29,754 | $12,247 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 168 | $19,488 | $8,534 | 43.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 109 | 143 | $28,171 | $8,440 | 30.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 170 | 252 | $39,564 | $7,111 | 18.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 113 | 128 | $19,840 | $5,968 | 30.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 142 | 924 | $34,188 | $3,575 | 10.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 90 | 112 | $9,856 | $3,530 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $9,170 | $3,154 | 34.4% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 27 | 30 | $6,810 | $2,221 | 32.6% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 13 | 13 | $5,876 | $2,138 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $5,814 | $1,695 | 29.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 13 | $5,629 | $1,370 | 24.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 41 | $3,444 | $1,140 | 33.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,428 | $362.56 | 25.4% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 18 | 79 | $49,928 | $24,448 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 105 | $18,137 | $7,690 | 42.4% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2022 | 18 | 52 | $18,892 | $7,486 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 138 | $16,008 | $7,254 | 45.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 92 | 116 | $22,852 | $6,719 | 29.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 102 | 120 | $18,600 | $5,787 | 31.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 140 | 206 | $32,342 | $5,724 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $12,576 | $4,571 | 36.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 118 | 809 | $29,933 | $3,317 | 11.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 60 | 74 | $6,512 | $2,452 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $6,669 | $1,885 | 28.3% |
About Stephanie Davitto, N.P
Stephanie Davitto, N.P is a Nurse Practitioner healthcare provider based in West Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2013. The National Provider Identifier (NPI) number assigned to this provider is 1053757047.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Davitto, N.P has received a total of $2,301 in payments from pharmaceutical and medical device companies, with $1,248 received in 2024. These payments were reported across 125 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,201).
As a Medicare-enrolled provider, Davitto has provided services to 1,944 Medicare beneficiaries, totaling 3,983 services with total Medicare billing of $146,620. Data is available for 3 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location West Lafayette, IN
- Active Since 05/16/2013
- Last Updated 09/13/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1053757047
Products in Payments
- TREMFYA (Drug) $421.77
- Otezla (Drug) $214.25
- DUPIXENT (Biological) $203.65
- SKYRIZI (Biological) $177.67
- Sotyktu (Drug) $173.41
- COSENTYX (Drug) $158.17
- OPZELURA (Drug) $146.67
- RINVOQ (Biological) $116.44
- EUCRISA (Drug) $103.99
- HUMIRA (Biological) $55.52
- Cimzia (Drug) $39.83
- Bimzelx (Biological) $29.51
- COSENTYX (Biological) $27.50
- LITFULO (Drug) $21.75
- HADLIMA (Drug) $20.07
- AKLIEF (Drug) $19.04
- BLU-U (Medical Supply) $16.10
- ADBRY (Biological) $13.78
- TALTZ (Drug) $13.43
- YCANTH (Drug) $12.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in West Lafayette
Dr. Mark Manning, Dnp, DNP
Nurse Practitioner — Payments: $7,136
Nurse Practitioner $7,136
Mr. Phillip Deturk, Np, NP
Nurse Practitioner — Payments: $4,332
Nurse Practitioner $4,332
Mrs. Shelley Velickoff, A.n.p, A.N.P
Nurse Practitioner — Payments: $3,431
Nurse Practitioner $3,431
Katrina Masterson, Np, NP
Nurse Practitioner — Payments: $3,264
Nurse Practitioner $3,264
Holly Howe, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $2,573
Nurse Practitioner $2,573
Theresa Coyner, Np, NP
Nurse Practitioner — Payments: $1,956
Nurse Practitioner $1,956